医薬品用ニコチンアミドアデニンジヌクレオチドの世界市場見通し2023年-2029年

◆英語タイトル：Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23FB0437）

◆商品コード：MMG23FB0437
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年2月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場規模と予測を収録しています。・世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：売上、2018年-2023年、2024年-2029年
・世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度:98%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

医薬品用ニコチンアミドアデニンジヌクレオチドのグローバル主要企業は、OYC Americas、Bontac Bio-engineering、Otto Chemie、Roche CustomBiotech、HiMedia Laboratories、NutriScience、EnzymeWorks、Hefei Home Sunshine Pharmaceutical Technology、Xi'an Yinherb Bio-Tech、Hygieia Biotech、Zhejiang Dazhan Biotechnology、Chemodex、GoldBio、FabriChemなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、医薬品用ニコチンアミドアデニンジヌクレオチドのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：タイプ別、2018年-2023年、2024年-2029年
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：タイプ別市場シェア、2022年
・純度:98%、純度:99%、その他

世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：用途別、2018年-2023年、2024年-2029年
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：用途別市場シェア、2022年
・製薬会社、研究所、その他

世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：地域・国別、2018年-2023年、2024年-2029年
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における医薬品用ニコチンアミドアデニンジヌクレオチドのグローバル売上、2018年-2023年
・主要企業における医薬品用ニコチンアミドアデニンジヌクレオチドのグローバル売上シェア、2022年
・主要企業における医薬品用ニコチンアミドアデニンジヌクレオチドのグローバル販売量、2018年-2023年
・主要企業における医薬品用ニコチンアミドアデニンジヌクレオチドのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
OYC Americas、Bontac Bio-engineering、Otto Chemie、Roche CustomBiotech、HiMedia Laboratories、NutriScience、EnzymeWorks、Hefei Home Sunshine Pharmaceutical Technology、Xi'an Yinherb Bio-Tech、Hygieia Biotech、Zhejiang Dazhan Biotechnology、Chemodex、GoldBio、FabriChem

*************************************************************

・調査・分析レポートの概要
医薬品用ニコチンアミドアデニンジヌクレオチド市場の定義
市場セグメント
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場規模
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場規模：2022年 VS 2029年
世界の医薬品用ニコチンアミドアデニンジヌクレオチド市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医薬品用ニコチンアミドアデニンジヌクレオチドの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医薬品用ニコチンアミドアデニンジヌクレオチド製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：純度:98%、純度:99%、その他
医薬品用ニコチンアミドアデニンジヌクレオチドのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：製薬会社、研究所、その他
医薬品用ニコチンアミドアデニンジヌクレオチドの用途別グローバル売上・予測

・地域別市場分析
地域別医薬品用ニコチンアミドアデニンジヌクレオチド市場規模 2022年と2029年
地域別医薬品用ニコチンアミドアデニンジヌクレオチド売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
OYC Americas、Bontac Bio-engineering、Otto Chemie、Roche CustomBiotech、HiMedia Laboratories、NutriScience、EnzymeWorks、Hefei Home Sunshine Pharmaceutical Technology、Xi'an Yinherb Bio-Tech、Hygieia Biotech、Zhejiang Dazhan Biotechnology、Chemodex、GoldBio、FabriChem
...

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Nicotinamide Adenine Dinucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Nicotinamide Adenine Dinucleotide. This report contains market size and forecasts of Pharmaceutical Grade Nicotinamide Adenine Dinucleotide in global, including the following market information:
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Pharmaceutical Grade Nicotinamide Adenine Dinucleotide companies in 2022 (%)
The global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity: 98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceutical Grade Nicotinamide Adenine Dinucleotide include OYC Americas, Bontac Bio-engineering, Otto Chemie, Roche CustomBiotech, HiMedia Laboratories, NutriScience, EnzymeWorks, Hefei Home Sunshine Pharmaceutical Technology and Xi’an Yinherb Bio-Tech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharmaceutical Grade Nicotinamide Adenine Dinucleotide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
[Total Market by Segment]
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Segment Percentages, by Type, 2022 (%)
Purity: 98%
Purity: 99%
Others
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Company
Research Laboratory
Others
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceutical Grade Nicotinamide Adenine Dinucleotide revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pharmaceutical Grade Nicotinamide Adenine Dinucleotide revenues share in global market, 2022 (%)
Key companies Pharmaceutical Grade Nicotinamide Adenine Dinucleotide sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Pharmaceutical Grade Nicotinamide Adenine Dinucleotide sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OYC Americas
Bontac Bio-engineering
Otto Chemie
Roche CustomBiotech
HiMedia Laboratories
NutriScience
EnzymeWorks
Hefei Home Sunshine Pharmaceutical Technology
Xi’an Yinherb Bio-Tech
Hygieia Biotech
Zhejiang Dazhan Biotechnology
Chemodex
GoldBio
FabriChem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceutical Grade Nicotinamide Adenine Dinucleotide, market overview.
Chapter 2: Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide market size in revenue and volume.
Chapter 3: Detailed analysis of Pharmaceutical Grade Nicotinamide Adenine Dinucleotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceutical Grade Nicotinamide Adenine Dinucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Overall Market Size
2.1 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size: 2022 VS 2029
2.2 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales: 2018-2029
3 Company Landscape
3.1 Top Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Players in Global Market
3.2 Top Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Companies Ranked by Revenue
3.3 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue by Companies
3.4 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales by Companies
3.5 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Players in Global Market
3.8.1 List of Global Tier 1 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size Markets, 2022 & 2029
4.1.2 Purity: 98%
4.1.3 Purity: 99%
4.1.4 Others
4.2 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue & Forecasts
4.2.1 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2023
4.2.2 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2024-2029
4.2.3 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue Market Share, 2018-2029
4.3 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales & Forecasts
4.3.1 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2023
4.3.2 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2024-2029
4.3.3 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales Market Share, 2018-2029
4.4 By Type – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Research Laboratory
5.1.4 Others
5.2 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue & Forecasts
5.2.1 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2023
5.2.2 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2024-2029
5.2.3 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue Market Share, 2018-2029
5.3 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales & Forecasts
5.3.1 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2023
5.3.2 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2024-2029
5.3.3 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales Market Share, 2018-2029
5.4 By Application – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2022 & 2029
6.2 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue & Forecasts
6.2.1 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2023
6.2.2 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2024-2029
6.2.3 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue Market Share, 2018-2029
6.3 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales & Forecasts
6.3.1 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2023
6.3.2 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2024-2029
6.3.3 By Region – Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2029
6.4.2 By Country – North America Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2029
6.4.3 US Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.4.4 Canada Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.4.5 Mexico Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2029
6.5.2 By Country – Europe Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2029
6.5.3 Germany Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.4 France Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.5 U.K. Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.6 Italy Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.7 Russia Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.8 Nordic Countries Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.5.9 Benelux Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2029
6.6.2 By Region – Asia Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2029
6.6.3 China Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.6.4 Japan Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.6.5 South Korea Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.6.6 Southeast Asia Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.6.7 India Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2029
6.7.2 By Country – South America Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2029
6.7.3 Brazil Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.7.4 Argentina Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales, 2018-2029
6.8.3 Turkey Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.8.4 Israel Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.8.5 Saudi Arabia Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
6.8.6 UAE Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 OYC Americas
7.1.1 OYC Americas Company Summary
7.1.2 OYC Americas Business Overview
7.1.3 OYC Americas Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.1.4 OYC Americas Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.1.5 OYC Americas Key News & Latest Developments
7.2 Bontac Bio-engineering
7.2.1 Bontac Bio-engineering Company Summary
7.2.2 Bontac Bio-engineering Business Overview
7.2.3 Bontac Bio-engineering Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.2.4 Bontac Bio-engineering Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.2.5 Bontac Bio-engineering Key News & Latest Developments
7.3 Otto Chemie
7.3.1 Otto Chemie Company Summary
7.3.2 Otto Chemie Business Overview
7.3.3 Otto Chemie Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.3.4 Otto Chemie Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.3.5 Otto Chemie Key News & Latest Developments
7.4 Roche CustomBiotech
7.4.1 Roche CustomBiotech Company Summary
7.4.2 Roche CustomBiotech Business Overview
7.4.3 Roche CustomBiotech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.4.4 Roche CustomBiotech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.4.5 Roche CustomBiotech Key News & Latest Developments
7.5 HiMedia Laboratories
7.5.1 HiMedia Laboratories Company Summary
7.5.2 HiMedia Laboratories Business Overview
7.5.3 HiMedia Laboratories Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.5.4 HiMedia Laboratories Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.5.5 HiMedia Laboratories Key News & Latest Developments
7.6 NutriScience
7.6.1 NutriScience Company Summary
7.6.2 NutriScience Business Overview
7.6.3 NutriScience Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.6.4 NutriScience Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.6.5 NutriScience Key News & Latest Developments
7.7 EnzymeWorks
7.7.1 EnzymeWorks Company Summary
7.7.2 EnzymeWorks Business Overview
7.7.3 EnzymeWorks Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.7.4 EnzymeWorks Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.7.5 EnzymeWorks Key News & Latest Developments
7.8 Hefei Home Sunshine Pharmaceutical Technology
7.8.1 Hefei Home Sunshine Pharmaceutical Technology Company Summary
7.8.2 Hefei Home Sunshine Pharmaceutical Technology Business Overview
7.8.3 Hefei Home Sunshine Pharmaceutical Technology Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.8.4 Hefei Home Sunshine Pharmaceutical Technology Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.8.5 Hefei Home Sunshine Pharmaceutical Technology Key News & Latest Developments
7.9 Xi’an Yinherb Bio-Tech
7.9.1 Xi’an Yinherb Bio-Tech Company Summary
7.9.2 Xi’an Yinherb Bio-Tech Business Overview
7.9.3 Xi’an Yinherb Bio-Tech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.9.4 Xi’an Yinherb Bio-Tech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.9.5 Xi’an Yinherb Bio-Tech Key News & Latest Developments
7.10 Hygieia Biotech
7.10.1 Hygieia Biotech Company Summary
7.10.2 Hygieia Biotech Business Overview
7.10.3 Hygieia Biotech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.10.4 Hygieia Biotech Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.10.5 Hygieia Biotech Key News & Latest Developments
7.11 Zhejiang Dazhan Biotechnology
7.11.1 Zhejiang Dazhan Biotechnology Company Summary
7.11.2 Zhejiang Dazhan Biotechnology Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Business Overview
7.11.3 Zhejiang Dazhan Biotechnology Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.11.4 Zhejiang Dazhan Biotechnology Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.11.5 Zhejiang Dazhan Biotechnology Key News & Latest Developments
7.12 Chemodex
7.12.1 Chemodex Company Summary
7.12.2 Chemodex Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Business Overview
7.12.3 Chemodex Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.12.4 Chemodex Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.12.5 Chemodex Key News & Latest Developments
7.13 GoldBio
7.13.1 GoldBio Company Summary
7.13.2 GoldBio Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Business Overview
7.13.3 GoldBio Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.13.4 GoldBio Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.13.5 GoldBio Key News & Latest Developments
7.14 FabriChem
7.14.1 FabriChem Company Summary
7.14.2 FabriChem Business Overview
7.14.3 FabriChem Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Major Product Offerings
7.14.4 FabriChem Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Sales and Revenue in Global (2018-2023)
7.14.5 FabriChem Key News & Latest Developments
8 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Production Capacity, Analysis
8.1 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Production Capacity, 2018-2029
8.2 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Supply Chain Analysis
10.1 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Industry Value Chain
10.2 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Upstream Market
10.3 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医薬品用ニコチンアミドアデニンジヌクレオチドの世界市場見通し2023年-2029年(Pharmaceutical Grade Nicotinamide Adenine Dinucleotide Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医薬品用ニコチンアミドアデニンジヌクレオチドの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp